Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer - Wikidata - wikimedia - TriplyDB

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

http://www.wikidata.org/entity/Q35982247

about

Gene therapy for carcinoma of the breast: Genetic immunotherapy CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours.EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts.Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.Induction of Tumor-Specific Cytotoxic T Lymphocytes from Regional Lymph Node Lymphocytes of Human Breast Cancer.Gene therapy strategies for carcinoma of the breast.In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.Fine-needle aspiration cytology in locally advanced breast adenocarcinoma: a case with complete response to preoperative chemotherapy in association with granulomatous inflammatory reaction.Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers.Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade

P2860

Q24797848-A6674B92-F594-4B66-B5C3-B0FEDDC65210 Q34447710-B5EB3B28-995C-46D7-A4B7-C07889DB4DF3 Q36053040-243E5DDE-D5A1-4B90-AA0D-3D90E0CD6045 Q36245546-3D490836-5C1D-43D1-862F-0C528FBCC2B8 Q36421948-4D95C21E-8D3B-4D01-8B48-2802C66268EB Q36623198-E05FEE86-6A49-4EB6-AC28-D12F1036B582 Q37138871-22910FAA-1CF4-4FB4-9330-D9545ABEA9C0 Q37267037-AAACB807-B3CE-41CE-BE54-B433F65EE7A0 Q37716586-7097BC5E-2578-4AFE-8D56-8D99F05DDDE6 Q38264173-B7AA627B-AA39-4261-95E8-B0107DCDBB52 Q40069517-E580C369-2B32-42B4-A609-F92EF7F4AF47 Q40075534-4827F0D4-1161-4FA7-8A92-9F5668E50CDD Q40840641-B7279246-A7B8-4EB2-87F7-70CBD6A9AA7F Q41540501-7979F72B-B9F0-46DC-BFC9-7E9AB531687E Q44762489-3053816C-DEFB-4D08-8875-8D315D3B44EC Q45946724-0CC72B70-02AC-4BFB-BE18-4B1301F54D2F Q48822605-9A957C77-FD7E-46D5-83C1-CD4B6829C066 Q53020046-7D574F9C-EE50-41DD-B8E6-97AF18AE4C80 Q56906350-F7B1C95A-E2C4-4D07-978C-659808845C49 Q59238302-19539624-9943-4848-9AF7-9CC2D7318CAB

P2860

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

http://www.wikidata.org/entity/Q35982247

description

1990 nî lūn-bûn

@nan

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

1990年论文

@zh

1990年论文

@zh-cn

name

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@ast

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@en

type

label

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@ast

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@en

prefLabel

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@ast

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@en

P1433

Q35982247-CEB22900-EABF-4A00-829B-444E9176AC17

P1476

Q35982247-7538F846-14EA-455B-80AF-C9521C0C4A4C

P2093

Q35982247-536727F1-8D25-4FD8-B842-AF526503DBB2

Q35982247-803A6891-968F-469C-9823-9F7C184C5136

Q35982247-F3AFF1EE-2056-4F9A-A4B3-3D636C6745A1

Q35982247-FED74900-3B30-4004-A61F-01E5988A0E1B

P2860

Q35982247-01322BA2-EFF5-45F0-ACEE-955BE720F796

Q35982247-0E631543-0B4E-46C9-8303-A27C81BB2A66

Q35982247-0F568FE8-450C-431B-AB59-DBFF622CEA27

Q35982247-36AB6AAF-DB36-45CC-B6F4-363C17C3AB27

Q35982247-3CF7650D-4566-42D7-83BD-117C25C35CF8

Q35982247-488D8E4E-8998-4085-A381-3DA72BF0CC41

Q35982247-64F45002-4166-4A0C-9C64-0765C9D44BA1

Q35982247-786CD3AE-7504-4A3F-A5A8-4507C9CED68D

Q35982247-7CF2BAAC-AAFB-454B-AEE7-7D47B09A43AC

Q35982247-889100F9-9096-42A8-B43F-63DEF94C085C

P2888

Q35982247-A6D2087D-A6D3-4BD6-B31D-1C83FB4BDC29

P304

Q35982247-22A92ABA-BABF-4162-845A-666A53EB0B01

P31

Q35982247-BE356F36-1D9C-47F1-9DF2-B5C26C4639B0

P356

Q35982247-2F6633F1-A5C5-4AF5-86E4-C42A4312C75D

P407

Q35982247-49A48E0F-7A05-4B49-B25E-3CF1377CAAA3

P433

Q35982247-5EBE7842-089D-4E97-BD55-F7BEDD6D5BFA

P478

Q35982247-07126DCE-77AA-4994-AC93-D551326E2122

P577

Q35982247-AC27D369-8C47-4890-A857-E388B323B859

P5875

Q35982247-3B361508-7AEE-449A-9D93-B73F5AD0D1E5

P6179

Q35982247-477F8724-E909-432A-9B1A-81DF66708BA5

P698

Q35982247-CD29C6D9-01FB-4F75-B64A-66334CC8E9F8

P932

Q35982247-6B7B0FB7-2BAB-499E-AEE5-1EDC6F56BFA4

P356

P1433

British Journal of Cancer

P1476

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

@en

P2093

Campbell AM

http://www.w3.org/2001/XMLSchema#string

George WD

http://www.w3.org/2001/XMLSchema#string

Mallon EA

http://www.w3.org/2001/XMLSchema#string

Whitford P

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.

In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.

Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens

Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease

Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies

Immunophenotype of the lymphoid cell infiltrates in breast carcinomas of low oestrogen receptor content.

Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Medullary carcinoma of the breast; a distinctive tumour type with a relatively good prognosis following radical mastectomy.

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

P2888

P304

971-975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1990.419

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

1990-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21032171

http://www.w3.org/2001/XMLSchema#string

P6179

1050006687

http://www.w3.org/2001/XMLSchema#string

P698

2124138

http://www.w3.org/2001/XMLSchema#string

P932

1971553

http://www.w3.org/2001/XMLSchema#string